LCN2 and infection: Also, when S. tmAvir was used for the secondary infection in AIEC-colonized mice there was a significant reduction in immunopathology (Fig 5F), a blunted TNFα release from explanted cecal tissue (Fig 5G), and a significant reduction in fecal lipocalin-2 output (Fig 5H).